FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lutz Uharek

Research Profile

Procedures

Living Beings

Disorders

Anatomy

Physiology

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Peter Dreger; Michael Hallek; Ute Hegenbart; Michael Kneba; Peter Paschka; Matthias Ritgen; Marianna Rossi; Christof Scheid; Norbert Schmitz; Andrea Schnaiter; Michael Stadler; Sebastian Böttcher; Andreas Bühler; Donald Bunjes; Raymonde Busch; Sascha Dietrich; Hartmut Döhner; Lutz Uharek; Matthias Zeis; Thorsten Zenz; Stephan Stilgenbauer
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial.
Christoph Mueller-Loebnitz; Helmut Ostermann; Max Topp; Lutz Uharek; Anke Franzke; Juergen Loeffler; Hermann Einsele
Immunological aspects of Candida and Aspergillus systemic fungal infections.
Il-Kang Na; Kathrin Rieger; Carmen Scheibenbogen; Igor Wolfgang Blau; Olga Blau; Mikalai Dziubianau; Anne Herholz; Désirée Kunkel; Angela Mensen; Eckhard Thiel; Lutz Uharek; Friedrich Wittenbecher; Andreas Thiel
Rabbit antithymocyte globulin (Thymoglobulin(R)) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lutz Uharek (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Peter Dreger; Michael Hallek; Ute Hegenbart; Michael Kneba; Peter Paschka; Matthias Ritgen; Marianna Rossi; Christof Scheid; Norbert Schmitz; Andrea Schnaiter; Michael Stadler; Sebastian Böttcher; Andreas Bühler; Donald Bunjes; Raymonde Busch; Sascha Dietrich; Hartmut Döhner; Lutz Uharek; Matthias Zeis; Thorsten Zenz; Stephan Stilgenbauer
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial.
Blood 2013;121(16):3284-8.
2013: Christoph Mueller-Loebnitz; Helmut Ostermann; Max Topp; Lutz Uharek; Anke Franzke; Juergen Loeffler; Hermann Einsele
Immunological aspects of Candida and Aspergillus systemic fungal infections.
Interdisciplinary perspectives on infectious diseases 2013;2013():102934.
2013: Il-Kang Na; Kathrin Rieger; Carmen Scheibenbogen; Igor Wolfgang Blau; Olga Blau; Mikalai Dziubianau; Anne Herholz; Désirée Kunkel; Angela Mensen; Eckhard Thiel; Lutz Uharek; Friedrich Wittenbecher; Andreas Thiel
Rabbit antithymocyte globulin (Thymoglobulin(R)) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients.
Haematologica 2013;98(1):23-30.
2012: Jochen Casper; Hermann Einsele; Mathias Freund; Sebastian Giebel; Jerzy Holowiecki; Tomasz Kruzel; K Larsson; Miroslaw Markiewicz; Heidrun A Mylius; Uwe Pichlmeier; Tapani Ruutu; K Schaefer-Eckart; Gernot Stuhler; Rudolf Trenschel; Lutz Uharek; Liisa Volin; Hannes Wandt; A R Zander; Joachim Baumgart; Igor Wolfgang Blau; M Bornhaeuser; Dietrich W Beelen
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning.
Bone marrow transplantation 2012;47(9):1171-7.
2012: K Frenzel; Susanne Ganepola; Detlev H Krüger; D Michel; Eckhard Thiel; Lutz Uharek; Jörg Hofmann
Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines.
Medical microbiology and immunology 2012;201(3):277-86.
2012: Clemens-Martin Wendtner; Jennie Zhang; Adrian Bloor; Francesc Bosch; Andreas Bühler; Steven Coutré; Luke Dreisbach; Alessandra Ferrajoli; Olga Frankfurt; Richard R Furman; Marco Gobbi; John G Gribben; Michael Hallek; Nyla A Heerema; Peter Hillmen; David D Hurd; Eva Kimby; Daruka Mahadevan; Laure Moutouh-de Parseval; Mikkael A Sekeres; Sheetal Shah; Stephan Stilgenbauer; Lutz Uharek; Asher A Chanan-Khan
Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.
Leukemia & lymphoma 2012;53(3):417-23.
2012: Thomas Burmeister; Birte Friedrichs; Nils Lachmann; Gunnar Lohm; Rolf Marschalek; Claus Meyer; Mara Molkentin; Stefan Schwartz; Carola Tietze-Bürger; Jörg Beyer; Igor Wolfgang Blau; Lutz Uharek
Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse.
Experimental hematology & oncology 2012;1(1):6.
2012: Inken Hilgendorf; Ernst Holler; Christian Junghanss; Günther Kundt; Malte Leithäuser; Axel Nogai; Eckhard Thiel; Lutz Uharek; Daniel Wolff; Mathias Freund; Joachim Hahn; Christoph Kahl
Chronic graft versus host disease but not the intensity of conditioning has impact on survival after allogeneic hematopoietic stem cell transplantation for advanced hematological diseases.
Onkologie 2012;35(9):487-92.
2011: Tapani Ruutu; Marc Schnitzler; Matthias Stelljes; Gernot Stuhler; Rudolf Trenschel; Lutz Uharek; Liisa Volin; Axel R Zander; Hermann Einsele; Juergen Finke; Mathias Freund; Sebastian Giebel; Martin Gramatzki; Jerzy Holowiecki; Joachim Kienast; Kajsa Larsson; Miroslaw Markiewicz; Heidrun A Mylius; Uwe Pichlmeier; Roland Repp; Joachim Baumgart; Dietrich W Beelen; Igor Wolfgang Blau; Jochen Casper
Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial.
Haematologica 2011;96(9):1344-50.
2011: Martin Neumann; Carola Tietze-Buerger; Lutz Uharek; Igor Wolfgang Blau; Olga Blau; Thomas Burmeister; Armin Gerbitz; Eckhard Thiel
Intrathecal application of donor lymphocytes in leukemic meningeosis after allogeneic stem cell transplantation.
Annals of hematology 2011;90(8):911-6.
2011: Thomas Lehrnbecher; Stanislaw Schmidt; Ulrike Koehl; Friedhelm R Schuster; Lutz Uharek; Thomas Klingebiel; Lars Tramsen
Adoptive antifungal T cell immunotherapy--into the clinic?
Medical mycology : official publication of the International Society for Human and Animal Mycology 2011;49 Suppl 1():S164-9.
2010: Peter Dreger; Hartmut Döhner; Matthias Ritgen; S Böttcher; Raymonde Busch; Sascha Dietrich; Donald Bunjes; Sandra Cohen; Jörg Schubert; Ute Hegenbart; Dietrich W Beelen; Matthias Zeis; Michael Stadler; Justin Hasenkamp; Lutz Uharek; Christof Scheid; Andreas Humpe; Thorsten Zenz; Dirk Winkler; Michael Hallek; Michael Kneba; Norbert Schmitz; Stephan Stilgenbauer
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial.
Blood 2010;116(14):2438-47.
2010: Wolfgang A Bethge; Thoralf Lange; Christoph Meisner; Stephanie von Harsdorf; Martin Bornhaeuser; Birgit Federmann; Michael Stadler; Lutz Uharek; Matthias Stelljes; Stefan Knop; Gerald Wulf; Rudolf Trenschel; Vladan Vucinic; Helmut Dittmann; Christoph Faul; Wichard Vogel; Lothar Kanz; Donald Bunjes
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study.
Blood 2010;116(10):1795-802.
2010: Karen Nahmod; Ciara Gentilini; Monica Vermeulen; Lutz Uharek; Yong Wang; Jialin Zhang; Heinz-Peter Schultheiss; Jorge Geffner; Thomas Walther
Impaired function of dendritic cells deficient in angiotensin II type 1 receptors.
The Journal of pharmacology and experimental therapeutics 2010;334(3):854-62.
2010: Markus M Heimesaat; Axel Nogai; Stefan Bereswill; Rita Plickert; André Fischer; Christoph Loddenkemper; Ulrich Steinhoff; Sandrine Tchaptchet; Eckhard Thiel; Marina A Freudenberg; Ulf B Göbel; Lutz Uharek
MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease.
Gut 2010;59(8):1079-87.
2010: Martin Schmidt-Hieber; S Schwarck; Andrea Stroux; Susanne Ganepola; P Reinke; Eckhard Thiel; Lutz Uharek; Igor Wolfgang Blau
Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion.
International journal of hematology 2010;91(5):877-85.
2010: Martin Schmidt-Hieber; Igor W Blau; Gregor Richter; Seval Türkmen; Christiane Bommer; Gundula Thiel; Heidemarie Neitzel; Andrea Stroux; Lutz Uharek; Eckhard Thiel; Olga Blau
Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantation.
Cancer genetics and cytogenetics 2010;198(2):135-43.
2009: Nicolaus Kröger; Ernst Holler; Guido Kobbe; Martin Bornhäuser; Rainer Schwerdtfeger; Herrad Baurmann; Arnon Nagler; Wolfgang Bethge; Matthias Stelljes; Lutz Uharek; Hannes Wandt; Andreas Burchert; Paolo Corradini; Jörg Schubert; Martin Kaufmann; Peter Dreger; Gerald G Wulf; Hermann Einsele; Tatjana Zabelina; Hans Michael Kvasnicka; Jürgen Thiele; Ronald Brand; Axel R Zander; Dietger Niederwieser; Theo M de Witte
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Blood 2009;114(26):5264-70.
2009: Ulrich Keilholz; Anne Letsch; Antonia Busse; Anne Marie Asemissen; Sandra Bauer; Igor Wolfgang Blau; Wolf-Karsten Hofmann; Lutz Uharek; Eckhard Thiel; Carmen Scheibenbogen
A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.
Blood 2009;113(26):6541-8.
2009: Silvia Heringer-Walther; Klaus Eckert; Sarah-Mai Schumacher; Lutz Uharek; Annika Wulf-Goldenberg; Florian Gembardt; Iduna Fichtner; Heinz-Peter Schultheiss; Kathy Rodgers; Thomas Walther
Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo.
Haematologica 2009;94(6):857-60.
2009: Martin Schmidt-Hieber; Janine Zweigner; Lutz Uharek; Igor Wolfgang Blau; Eckhard Thiel
Central nervous system infections in immunocompromised patients: update on diagnostics and therapy.
Leukemia & lymphoma 2009;50(1):24-36.
2008: Olaf Penack; Lars Fischer; Andrea Stroux; Chiara Gentilini; Axel Nogai; Arne Muessig; Kathrin Rieger; Susanne Ganepola; Wolfgang Herr; Ralf G Meyer; Eckhard Thiel; Lutz Uharek
Serotherapy with thymoglobulin and alemtuzumab differentially influences frequency and function of natural killer cells after allogeneic stem cell transplantation.
Bone marrow transplantation 2008;41(4):377-83.
2007: Olaf Penack; Lars Fischer; Chiara Gentilini; Axel Nogai; Arne Muessig; Kathrin Rieger; Susanne Ganepola; Eckhard Thiel; Lutz Uharek
The type of ATG matters -- natural killer cells are influenced differentially by Thymoglobulin, Lymphoglobulin and ATG-Fresenius.
Transplant immunology 2007;18(2):85-7.
2007: Martin Schmidt-Hieber; Igor Wolfgang Blau; Stefan Schwartz; Lutz Uharek; Klaus Weist; Tim Eckmanns; D Jonas; Henning Rüden; Eckhard Thiel; Christian Brandt
Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients.
International journal of hematology 2007;86(2):158-62.
2007: Almuth Berthold; Astrid Haibel; Natascha Brandes; Lothar W Kroh; Ulrich Gross; Lutz Uharek; Helmut Schubert
Biocompatible porous ceramics for the cultivation of hematopoietic cells.
Journal of materials science. Materials in medicine 2007;18(7):1333-8.
2007: Martin Schmidt-Hieber; Igor Wolfgang Blau; Rudolf Trenschel; R Andreesen; Gernot Stuhler; Hermann Einsele; Lothar Kanz; Ulrich Keilholz; Olga Marinets; Dietrich W Beelen; Axel A Fauser; Liisa Volin; T Ruutu; Lutz Uharek; Thomas Fietz; Wolfgang Knauf; Werner Hopfenmüller; Eckhard Thiel; M Freund; Jochen Casper
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma.
Bone marrow transplantation 2007;39(7):389-96.
2007: Susanne Ganepola; Chiara Gentilini; U Hilbers; Thoralf Lange; Kathrin Rieger; Jörg Hofmann; M Maier; U. Liebert; Dietger Niederwieser; Elisabeth Engelmann; Regine Heilbronn; Eckhard Thiel; Lutz Uharek
Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.
Bone marrow transplantation 2007;39(5):293-9.
2007: Ralf G Meyer; Cedrik Michael Britten; Daniela Wehler; Klaus Bender; Georg Hess; Abdo Konur; Udo Hartwig; Thomas Wehler; Andrew J Ullmann; Chiara Gentilini; Lutz Uharek; Christoph Huber; Karin Kolbe; Wolfgang Herr
Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reduced-intensity transplantation.
Blood 2007;109(1):374-82.
2006: Timm H Westhoff; Walter Zidek; Lutz Uharek; Juliana Steinhoff-Georgieva; Markus van der Giet
Impairment of renal function in Schnitzler's syndrome.
Journal of nephrology 2006;19(5):660-3.
2006: Daniel Wolff; Stefan Wilhelm; Joachim Hahn; Chiara Gentilini; Inken Hilgendorf; Beate Steiner; Christoph Kahl; Christian Junghanss; Gernot Hartung; Jochen Casper; Lutz Uharek; Ernst Holler; Mathias Freund
Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.
Bone marrow transplantation 2006;38(6):445-51.
2006: Lars Fischer; Olaf Penack; Chiara Gentilini; Axel Nogai; Arne Muessig; Eckhard Thiel; Lutz Uharek
The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells.
Experimental hematology 2006;34(6):753-9.
2006: Robert Godal; Ulrich Keilholz; Lutz Uharek; Anne Letsch; Anne Marie Asemissen; Antonia Busse; Il-Kang Na; Eckhard Thiel; Carmen Scheibenbogen
Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2.
Blood 2006;107(8):3205-11.
2006: Kathrin Rieger; Christoph Loddenkemper; Jochen Maul; Thomas Fietz; Daniel Wolff; Harald Terpe; Beate Steiner; Erika Berg; Stephan Miehlke; Martin Bornhäuser; Thomas Schneider; Martin Zeitz; Harald Stein; Eckhard Thiel; Rainer Duchmann; Lutz Uharek
Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.
Blood 2006;107(4):1717-23.
2006: Jakob R Passweg; Ulrike Koehl; Lutz Uharek; Sandrine Meyer-Monard; André Tichelli
Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation.
Best practice & research. Clinical haematology 2006;19(4):811-24.
2006: Thomas Fietz; Lutz Uharek; Chiara Gentilini; Arne Muessig; Kathrin Rieger; Olga Marinets; Dirk Sandrock; Dieter L Munz; Bertram Glaß; Eckhard Thiel; Igor Wolfgang Blau
Allogeneic hematopoietic cell transplantation following conditioning with 90Y-ibritumomab-tiuxetan.
Leukemia & lymphoma 2006;47(1):59-63.
2005: Martin Schmidt-Hieber; Thomas Fietz; Wolfgang Knauf; Lutz Uharek; Werner Hopfenmüller; Eckhard Thiel; Igor Wolfgang Blau
Efficacy of the interleukin-2 receptor antagonist basiliximab in steroid-refractory acute graft-versus-host disease.
British journal of haematology 2005;130(4):568-74.
2005: Olaf Penack; Karl-Jürgen Wolf; Lutz Uharek
Air embolism simulating atypical pneumonia.
British journal of haematology 2005;130(4):468.
2005: Olaf Penack; Chiara Gentilini; Lars Fischer; Anne Marie Asemissen; Carmen Scheibenbogen; Eckhard Thiel; Lutz Uharek
CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.
Leukemia 2005;19(5):835-40.
2005: Jakob R Passweg; Martin Stern; Ulrike Koehl; Lutz Uharek; André Tichelli
Use of natural killer cells in hematopoetic stem cell transplantation.
Bone marrow transplantation 2005;35(7):637-43.
2004: Wolf-Karsten Hofmann; Claudia D Baldus; Lutz Uharek; Eckhard Thiel
Therapeutic spectrum in the treatment of myelodysplastic syndromes.
Expert opinion on pharmacotherapy 2004;5(12):2451-8.
2004: Thoralf Lange; Michael W N Deininger; Ronald Brand; Ute Hegenbart; Haifa-Kathrin Al-Ali; Rainer Krahl; W Poenisch; Lutz Uharek; Sabine Leiblein; Chiara Gentilini; Effie W Petersdorf; Rainer Storb; Dietger Niederwieser
BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.
Leukemia 2004;18(9):1468-75.
2003: Gernot Hartung; Matthias Zeis; Bertram Glaß; Peter Dreger; Jörg Steinmann; Norbert Schmitz; Lutz Uharek
Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
Bone marrow transplantation 2003;32(1):49-56.
2003: Jan Stritzke; Tim Zunkel; Jörg Steinmann; Norbert Schmitz; Lutz Uharek; Matthias Zeis
Therapeutic effects of idiotype vaccination can be enhanced by the combination of granulocyte-macrophage colony-stimulating factor and interleukin 2 in a myeloma model.
British journal of haematology 2003;120(1):27-35.
2002: Matthias Zeis; Tim Zunkel; Jörg Steinmann; Norbert Schmitz; Lutz Uharek
Enhanced antitumoral effectiveness of idiotype vaccination induced by the administration of Flt3 ligand combined with interleukin 2 against a murine myeloma.
British journal of haematology 2002;117(1):93-102.
2002: Matthias Zeis; H Frenzke; Norbert Schmitz; Lutz Uharek; Jörg Steinmann
Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice.
Bone marrow transplantation 2002;29(3):213-21.
2001: C Lehmann; Matthias Zeis; Lutz Uharek
Activation of natural killer cells with interleukin 2 (IL-2) and IL-12 increases perforin binding and subsequent lysis of tumour cells.
British journal of haematology 2001;114(3):660-5.
2001: Matthias Zeis; Jörg Steinmann; E Petrela; Gernot Hartung; Norbert Schmitz; Lutz Uharek
Transfer of idiotypic protein primed allogeneic marrow grafts elicits potent graft-versus-myeloma effects in mice.
Bone marrow transplantation 2001;27(3):279-85.
2001: Matthias Zeis; Lutz Uharek; Gernot Hartung; Bertram Glaß; Jörg Steinmann; Norbert Schmitz
Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in mice.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(2):136-44.
2000: C Lehmann; Matthias Zeis; Norbert Schmitz; Lutz Uharek
Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells.
Blood 2000;96(2):594-600.
1999: Peter Dreger; K Viehmann; Nils von neuhoff; T Glaubitz; O Petzoldt; Bertram Glaß; Lutz Uharek; Peter Rautenberg; M Suttorp; B Mills; Peggie Mitsky; Norbert Schmitz
Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery.
Bone marrow transplantation 1999;24(2):153-61.
1999: C Lehmann; Bertram Glaß; Matthias Zeis; Norbert Schmitz; Lutz Uharek
Investigating the lysis of small-cell lung cancer cell lines by activated natural killer (NK) cells with a fluorometric assay for NK-cell-mediated cytotoxicity.
Cancer immunology, immunotherapy : CII 1999;48(4):209-13.
1998: Matthias Zeis; Lutz Uharek; Bertram Glaß; W Vosskötter; Peter Dreger; Norbert Schmitz; Jörg Steinmann
Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
Experimental hematology 1998;26(11):1068-73.
1998: Gernot Hartung; Lutz Uharek; Matthias Zeis; Bertram Glaß; Jörg Steinmann; Peter Dreger; Martin Krönke; Norbert Schmitz
Superior antileukemic activity of murine peripheral blood progenitor cell (PBPC) grafts mobilized by G-CSF and stem cell factor (SCF) as compared to G-CSF alone.
Bone marrow transplantation 1998;21 Suppl 3():S16-20.
1998: Bertram Glaß; Lutz Uharek; Gernot Hartung; Matthias Zeis; Jörg Steinmann; Peter Dreger; Martin Krönke; Norbert Schmitz
Immunotherapeutic aspects of allogeneic peripheral progenitor cells.
Bone marrow transplantation 1998;21 Suppl 3():S3-8.
1998: Peter Dreger; Nils von neuhoff; Rolf Kuse; Ruth Sonnen; Bertram Glaß; Lutz Uharek; Robert Schoch; Helmut Löffler; Norbert Schmitz
Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
British journal of cancer 1998;77(12):2291-7.
1998: Lutz Uharek; Bertram Glaß; Matthias Zeis; Peter Dreger; Jörg Steinmann; Helmut Löffler; Norbert Schmitz
Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
Experimental hematology 1998;26(2):93-9.
1997: Bertram Glaß; Lutz Uharek; Matthias Zeis; Peter Dreger; Helmut Löffler; Jörg Steinmann; Norbert Schmitz
Allogeneic peripheral blood progenitor cell transplantation in a murine model: evidence for an improved graft-versus-leukemia effect.
Blood 1997;90(4):1694-700.
1997: Peter Dreger; Bertram Glaß; Lutz Uharek; Matthias Zeis; Norbert Schmitz
Allogenic transplantation of mobilized peripheral blood progenitor cells: towards tailored cell therapy.
International journal of hematology 1997;66(1):1-11.
1997: Peter Dreger; Nils von neuhoff; Rolf Kuse; Ruth Sonnen; Bertram Glaß; Lutz Uharek; H Bartels; Helmut Löffler; Norbert Schmitz
Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(4):401-3.
1997: Matthias Zeis; Lutz Uharek; Bertram Glaß; Jörg Steinmann; Peter Dreger; Winfried Gassmann; Norbert Schmitz
Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukaemia effect in mice.
British journal of haematology 1997;96(4):757-61.
1996: Lutz Uharek; Matthias Zeis; Bertram Glaß; Jörg Steinmann; Peter Dreger; Winfried Gassmann; Norbert Schmitz; Wolfgang Müller-Ruchholtz
High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2.
Leukemia 1996;10(11):1758-64.
1996: Peter Dreger; Bertram Glaß; Lutz Uharek; Norbert Schmitz
Allogeneic peripheral blood progenitor cells: current status and future directions.
Journal of hematotherapy 1996;5(4):331-7.
1996: Bertram Glaß; Lutz Uharek; Matthias Zeis; H Loeffler; W Mueller-Ruchholtz; Winfried Gassmann
Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells.
British journal of haematology 1996;93(2):412-20.
1995: T Sebens; Lutz Uharek; Bertram Glaß; Wolfgang Müller-Ruchholtz; Jörg Steinmann
Allogeneic mouse T cell lines distinguish three Balb/c leukemias from each other and from non-leukemic lymphocytes.
Bone marrow transplantation 1995;16(3):443-9.
1995: Matthias Zeis; Lutz Uharek; Bertram Glaß; T Gaska; Jörg Steinmann; Winfried Gassmann; Helmut Löffler; Wolfgang Müller-Ruchholtz
Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice.
Transplantation 1995;59(12):1734-6.
1995: Jörg Steinmann; Bertram Glaß; C Herwartz; M Salomo; T Sebens; Lutz Uharek; Wolfgang Müller-Ruchholtz
In vitro generation of allogeneic rather than syngeneic cytotoxic T cells for leukemia therapy.
Transplantation proceedings 1995;27(1):637-9.
1995: M Salomo; Jörg Steinmann; Bertram Glaß; C Herwartz; Lutz Uharek; Winfried Gassmann; Wolfgang Müller-Ruchholtz
Leukemia-specific allogeneic donor T cells: quantification by limiting dilution assay.
Bone marrow transplantation 1995;15(2):179-86.
1994: Matthias Zeis; Lutz Uharek; Bertram Glaß; T Gaska; Winfried Gassmann; W Mueller-Ruchholtz
Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
Bone marrow transplantation 1994;14(5):711-5.
1994: Lutz Uharek; Bertram Glaß; T Gaska; Winfried Gassmann; H Loeffler; W Mueller-Ruchholtz
Influence of donor lymphocytes on the incidence of primary graft failure after allogeneic bone marrow transplantation in a murine model.
British journal of haematology 1994;88(1):79-87.
1994: F Eggert; Lutz Uharek; Wolfgang Müller-Ruchholtz; Roman Ferstl
MHC-associated and MHC-independent urinary chemosignals in mice are expressed via the hematopoietic system.
Neuropsychobiology 1994;30(1):42-5.
1993: F Eggert; Lutz Uharek; Wolfgang Müller-Ruchholtz; Roman Ferstl
The hematopoietic system influences odor specificity in mice and rats.
Neuropsychobiology 1993;27(2):108-11.
1993: Lutz Uharek; Bertram Glaß; T Gaska; M Zeiss; Winfried Gassmann; Helmut Löffler; Wolfgang Müller-Ruchholtz
Natural killer cells as effector cells of graft-versus-leukemia activity in a murine transplantation model.
Bone marrow transplantation 1993;12 Suppl 3():S57-60.
1993: Bertram Glaß; Lutz Uharek; T Gaska; Winfried Gassmann; Helmut Löffler; Wolfgang Müller-Ruchholtz
The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Bone marrow transplantation 1993;12 Suppl 3():S41-7.
1992: Lutz Uharek; Bertram Glaß; Winfried Gassmann; V Eckstein; Jörg Steinmann; H Loeffler; W Mueller-Ruchholtz
Engraftment of allogeneic bone marrow cells: experimental investigations on the role of cell dose, graft-versus-host reactive T cells and pretransplant immunosuppression.
Transplantation proceedings 1992;24(6):3023-5.
1992: Bertram Glaß; Lutz Uharek; Winfried Gassmann; B Focks; H Bolouri; H Loeffler; W Mueller-Ruchholtz
Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease.
Annals of hematology 1992;64(6):255-9.
1992: Lutz Uharek; Winfried Gassmann; Bertram Glaß; Jörg Steinmann; H Loeffler; W Mueller-Ruchholtz
Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation.
Blood 1992;79(6):1612-21.
1992: D Luszyk; F Eggert; Lutz Uharek; Bertram Glaß; Wolfgang Müller-Ruchholtz; Roman Ferstl
[Characteristics of changes of personal odor after experimental bone marrow transplantation].
Zeitschrift für experimentelle und angewandte Psychologie 1992;39(2):249-62.
1991: Winfried Gassmann; Lutz Uharek; A Erbersdobler; Bertram Glaß; H U Wottge; Norbert Schmitz; Helmut Löffler; W Mueller-Ruchholtz
High-dose cytostatic agents in allogeneic bone marrow transplantation: comparison of the engraftment promoting potential.
British journal of haematology 1991;78(3):310-8.
1991: Lutz Uharek; Winfried Gassmann; D Fleischhauer; H U Wottge; H Loeffler; W Mueller-Ruchholtz
Effect of post-transplant methotrexate, cyclosporin A and prednisolone on graft rejection after allogeneic bone marrow transplantation.
Bone marrow transplantation 1991;7(1):17-22.
1991: Winfried Gassmann; A Erbersdobler; Lutz Uharek; Bertram Glaß; Helmut Löffler; W Mueller-Ruchholtz
Ifosfamide and ACNU in experimental allogeneic bone marrow transplantation.
Journal of cancer research and clinical oncology 1991;117 Suppl 4():S224-7.
1990: E Hamelmann; H U Wottge; Winfried Gassmann; Lutz Uharek; Wolfgang Müller-Ruchholtz
Induction of tolerance after facilitation of engraftment with a monoclonal antibody anti-MHC class II in MHC fully allogeneic transplantation.
Transplantation proceedings 1990;22(5):2340-1.
1989: Lutz Uharek; Winfried Gassmann; D Fleischhauer; H U Wottge; H Loeffler; Wolfgang Müller-Ruchholtz
Comparison of immunosuppressive agents for prevention of graft rejection in allogeneic bone marrow transplantation.
Transplantation proceedings 1989;21(1 Pt 3):3042-4.
1988: Winfried Gassmann; Lutz Uharek; H U Wottge; Norbert Schmitz; Helmut Löffler; W Mueller-Ruchholtz
Comparison of cyclophosphamide, cytarabine, and etoposide as immunosuppressive agents before allogeneic bone marrow transplantation.
Blood 1988;72(5):1574-9.